ORIC Pharmaceuticals Statistics

Total Valuation

ORIC has a market cap or net worth of $837.75 million. The enterprise value is $557.50 million.

Market Cap	837.75M
Enterprise Value	557.50M

Important Dates

The last earnings date was Tuesday, August 12, 2025, after market close.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ORIC has 85.22 million shares outstanding. The number of shares has increased by 14.90% in one year.

Current Share Class	85.22M
Shares Outstanding	85.22M
Shares Change (YoY)	+14.90%
Shares Change (QoQ)	+9.97%
Owned by Insiders (%)	1.63%
Owned by Institutions (%)	66.97%
Float	48.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.30
P/TBV Ratio	2.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.13, with a Debt / Equity ratio of 0.01.

Current Ratio	16.13
Quick Ratio	15.65
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -43.82% and return on invested capital (ROIC) is -29.19%.

Return on Equity (ROE)	-43.82%
Return on Assets (ROA)	-27.69%
Return on Invested Capital (ROIC)	-29.19%
Return on Capital Employed (ROCE)	-45.52%
Revenue Per Employee	n/a
Profits Per Employee	-$1.19M
Employee Count	115
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.72% in the last 52 weeks. The beta is 1.69, so ORIC's price volatility has been higher than the market average.

Beta (5Y)	1.69
52-Week Price Change	+18.72%
50-Day Moving Average	10.23
200-Day Moving Average	8.48
Relative Strength Index (RSI)	45.64
Average Volume (20 Days)	1,276,871

Short Selling Information

The latest short interest is 6.76 million, so 7.93% of the outstanding shares have been sold short.

Short Interest	6.76M
Short Previous Month	12.29M
Short % of Shares Out	7.93%
Short % of Float	13.86%
Short Ratio (days to cover)	5.99

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-149.67M
Pretax Income	-101.76M
Net Income	-137.25M
EBITDA	-148.49M
EBIT	-149.67M
Earnings Per Share (EPS)	-$1.89

Full Income Statement

Balance Sheet

The company has $282.51 million in cash and $4.81 million in debt, giving a net cash position of $277.70 million or $3.26 per share.

Cash & Cash Equivalents	282.51M
Total Debt	4.81M
Net Cash	277.70M
Net Cash Per Share	$3.26
Equity (Book Value)	324.00M
Book Value Per Share	4.15
Working Capital	273.07M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ORIC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.90%
Shareholder Yield	-14.90%
Earnings Yield	-16.43%
FCF Yield	n/a

Analyst Forecast

The average price target for ORIC is $18.25, which is 85.66% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.25
Price Target Difference	85.66%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-7.69%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1